当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Urashima M*, Nakashima A, Hama T, Suzuki Y, Ohdaira H, Akiba T, Suzuki M, Noya M, Tsumi Y, Mafune A, Toda K, Yokoyama K, Wada K, Kojima H and Okamoto A
Background: The UDP-glucuronosyltransferase 2 family polypeptide B17 (UGT2B17) detoxifies carcinogens found in tobacco smoke and ethanol in alcoholic drinks. Tobacco carcinogens and ethanol synergistically raise the risk for upper aero digestive tract (UADT) cancer (head and neck squamous carcinoma, and esophageal cancer). Deletion polymorphism of the UGT2B17 gene (UGT2B17-deletion) is a much more common copy number variant among Japanese than other populations. Thus, we conducted a nested and age/gender-matched case-control (1:1) study to determine if UGT2B17-deletion associates with cancer risk, including UADT-cancer in Japanese.
Methods: Polymerase chain reaction was used to determine UGT2B17-deletion using DNA samples derived from peripheral blood or tumor tissue. Cases were cancer patients and controls were non-cancer patients. Nonconditional and conditional logistic regression analyses were performed. To overcome the issue of multiple-testing, Bonferroni correction was applied to set p < 0.003 as statistically significant.
Results: A total of 3,092 patients were enrolled. UGT2B17-deletion was detected in 74% of the 1,887 non-cancer patients and 77% of the 1,205 cancer patients. UGT2B17-deletion was a significant risk factor for UADT-cancer development: odds ratio, 2.07; 95% confidence interval, 1.34 to 3.20, p=0.001. In contrast, UGT2B17-deletion was not a risk for any other type of cancers represented in our study population.
Conclusions: These results suggest that UGT2B17-deletion may associate to increase the risk of UADT-cancer in Japanese.